06/04/2026
Arthritis Research Canada scientists, trainees, and collaborators continued to share research at EULAR 2026 that is helping improve arthritis care, diagnosis, and outcomes.
- Dr. Diane Lacaille and Dr. Susan Bartlett conducted discussion groups with people living with arthritis and arthritis care professionals to inform the design of FlexCAre, a new, more flexible way of delivering arthritis care. The goal is to provide more individualized care that better meets the diverse needs of people with arthritis.
- Dr. Lihi Eder tested a newly developed tool to support early diagnosis of psoriatic arthritis by measuring inflammation at sites where tendons insert into bone.]
- Dr. Lihi Eder also presented research showing that disease activity, including joint pain and swelling, is worse during the perimenopausal period for women with psoriatic arthritis, drawing attention to hormonal influences on the disease.
- In a population-based study in Catalonia, Spain, led by Dr. Antonio Avina-Zubieta, researchers found that despite advances in treatment for rheumatoid arthritis, increased mortality risk persists, largely due to an increased risk of other chronic diseases linked to inflammation. The findings highlight the importance of integrated care.
- Arthritis Research Canada trainee Ellen Wang presented findings from a patient-led survey that sheds light on gastrointestinal symptoms and the dietary impacts of dry mouth—an often overlooked aspect of Sjögren’s syndrome.
- Dr. Natalie McCormick and Dr. Hyon Choi reported that SGLT2 inhibitors, a class of medications used to treat heart failure, prevents gout and gout flares among people living with heart failure.
For a full list of conference abstracts, visit: https://ow.ly/QmA450Z7r6L
